Hydroxyurea and Lovaza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxyurea (hydroxyurea) and Lovaza (omega-3-acid ethyl esters). Common drug interactions include abortion induced among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxyurea and Lovaza. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 17,340 Lovaza users. Check the latest studies of Lovaza.



On Aug, 12, 2026

17 people who take Hydroxyurea and Lovaza together, and have interactions are studied.

Hydroxyurea and Lovaza drug interactions.

What are the common drug interactions of Hydroxyurea and Lovaza, by gender? *:

female:

  1. Abortion induced (medically referred abortion)
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Flushing (the warm, red condition of human skin)
  4. Rash papular (redness with papule)
  5. Skin burning sensation
  6. Asthenia (weakness)
  7. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  8. Hypophagia (reduced food intake)
  9. Nausea (feeling of having an urge to vomit)
  10. Platelet count increased

male:

  1. Diarrhoea
  2. Disease progression
  3. Adverse drug reaction
  4. Aphagia (inability or refusal to swallow)
  5. Asthenia (weakness)
  6. Ataxia (loss of full control of bodily movements)
  7. Blood magnesium decreased
  8. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  9. Candidiasis (candidiasis or thrush is a fungal infection)
  10. Chest pain

What are the common drug interactions of Hydroxyurea and Lovaza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Ataxia (loss of full control of bodily movements)
  2. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  3. Dizziness
  4. Headache (pain in head)
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting

40-49:

n/a

50-59:

  1. Abortion induced (medically referred abortion)
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Flushing (the warm, red condition of human skin)
  4. Rash papular (redness with papule)
  5. Skin burning sensation

60+:

  1. Platelet count decreased
  2. Vomiting
  3. Diarrhoea
  4. Erectile dysfunction
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Gout (uric acid crystals building up in the body)
  8. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  9. Heart rate increased
  10. Herpes virus infection

What are the existing conditions these people have? *

  1. Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 11.76%
  2. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 11.76%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 11.76%
  4. High Blood Pressure: 2 people, 11.76%
  5. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 11.76%
  6. Thrombocytopenia (decrease of platelets in blood): 1 person, 5.88%
  7. Stress And Anxiety: 1 person, 5.88%
  8. Rosacea (a skin condition that causes facial redness): 1 person, 5.88%
  9. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.88%
  10. Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyurea and Lovaza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydroxyurea and Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyurea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovaza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyurea and omega-3-acid ethyl esters (the active ingredients of Hydroxyurea and Lovaza, respectively), and Hydroxyurea and Lovaza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: